Assessment of GnRH peptides and irrelevant compounds on WT and hE90K-desK191 mutant IP production. (Upper) Cells were transfected with 100 ng of human WT GnRHR cDNA and left unrescued. Various GnRH peptides or irrelevant compounds were added in medium alone (1 μg/mL) or with 10−9 M Buserelin to show agonistic or antagonistic activity on total IP production. For comparison, a maximal concentration (10−9 M) of the GnRH agonist, Buserelin, produces a response of 6,517 ± 93 cpm. (Lower) Cells were transfected with 100 ng of hE90K-desK191 cDNA, then rescued with pharmacoperone (In3). The In3 was then washed out. After 18 h of preloading the cells with 3H-inositol, the cells were incubated with 1 μg/mL GnRH analogs or irrelevant compounds to assess agonistic or antagonistic activity on total IP production. Group A (Asp2, Glu2, Gly2); Group B (DPhe2DAla6, DGlu1DPhe2DTrp3DLys6, DesHis2-GnRH, DLeu2DLys6, DPhe2DPhe6); Group C (sCalcitonin, Vapreotide, hGalanin, GHRP6, TRH); Group D (In3, Acyline, Azaline B, FE486, Nal-Arg, Nal-Glu, Antide). For comparison, a maximal concentration (10−7 M) of the GnRH agonist, Buserelin, produces a response of 11,144 ± 1,098 cpm.